Am. J. Respir. Crit. Care Med., Volume 163, Number 5, April 2001, 1074-1080

Interpreting Improvement in Expiratory Flows after Lung Volume Reduction Surgery in Terms of Flow Limitation Theory

EDWARD P. INGENITO, STEPHEN H. LORING, MARILYN L. MOY, STEVEN J. MENTZER, SCOTT J. SWANSON, and JOHN J. REILLY

Division of Pulmonary and Critical Care Medicine and Thoracic Surgery, Brigham and Women's Hospital, and Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Spirometry and pulmonary mechanics were measured pre- and postoperatively in 37 patients undergoing bilateral lung volume reduction surgery (LVRS). The relative contributions of changes in compliance (CL), recoil pressures (PTLC), small airway conductance (Gu), and airway closing pressures (Ptm') to changes in expiratory flows were examined with a Taylor series expansion of the Pride- Permutt model of flow limitation. The resulting variational expression, max = GuPel + PelGu  GuPtm'  Ptm'Gu  GuPtm', was then used to describe how the peak flow rate (max) depends on preoperative Gu, P TLC, Ptm', and on changes () in these parameters after surgery. After LVRS, both FEV₁ and max increased significantly ( FEV₁ = 28 ± 44%; max = 78 ± 132%), and changes in FEV₁ and max correlated closely (r = 0.74, p < 0.001). Among responders (FEV₁  12%; n = 19; FEV₁ = 60 ± 38%), PTLC increased (8.8 ± 2.8 to 12.2 ± 4.7 cm H₂O) and the time constant for expiration ( = CL/Gu) decreased (2.67 ± 0.62 to 2.35 ± 0.55 s), while Ptm', CL, and Gu did not change. GuPel, the change in recoil weighted by preoperative conductance upstream of the flow-limiting site, accounted for 72% of the improvement in max. Among nonresponders ( FEV₁ = 6 ± 15%, n = 18),  increased significantly, contributing to a decline in FEV₁/FVC ratio. PelGu decreased (0.25 ± 0.68, p = 0.013), accounting for all of the decline in max. This analysis suggests that ( 1) improvement in expiratory flows after LVRS is largely due to increases in recoil pressure; (2) large improvements in FEV₁ can occur without changes in Gu or Ptm', arguing that LVRS has little effect on airway resistance or closure; and (3) large changes in PTLC can occur without changes in CL, supporting arguments of Fessler and Permutt (Am J Respir Crit Care Med 1998;157:715-722) that "resizing of the lung to chest wall" is the primary mechanism by which LVRS improves lung function.

This article has been cited by other articles:

				H. E. Fessler, S. M. Scharf, E. P. Ingenito, R. J. McKenna Jr., and A. Sharafkhaneh Physiologic Basis for Improved Pulmonary Function after Lung Volume Reduction Proceedings of the ATS, May 1, 2008; 5(4): 416 - 420. [Abstract] [Full Text] [PDF]

				E. P. Ingenito, D. E. Wood, and J. P. Utz Bronchoscopic Lung Volume Reduction in Severe Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 454 - 460. [Abstract] [Full Text] [PDF]

				M. Decramer Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation Eur. Respir. J., November 16, 2003; 22(47_suppl): 47S - 56s. [Abstract] [Full Text] [PDF]

				E. P. Ingenito, S. H. Loring, M. L. Moy, S. J. Mentzer, S. J. Swanson, and J. J. Reilly Physiological characterization of variability in response to lung volume reduction surgery J Appl Physiol, January 1, 2003; 94(1): 20 - 30. [Abstract] [Full Text] [PDF]

				O. Diaz, P. Begin, B. Torrealba, E. Jover, and C. Lisboa Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD Eur. Respir. J., December 1, 2002; 20(6): 1490 - 1498. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]